Reliefband Technologies
Private Company
Funding information not available
Overview
Reliefband Technologies is a San Diego-based medical device company with a 25-year history, focused on a proprietary, non-invasive neuromodulation platform for nausea control. Its FDA-cleared wearable device is positioned as a drug-free alternative for multiple high-prevalence indications, including motion sickness, pregnancy-related nausea, and chemotherapy-induced nausea and vomiting (CINV). The company has successfully transitioned from hospital-proven technology to a direct-to-consumer (DTC) model, offering several product tiers. Its core value proposition is fast-acting, side-effect-free relief, supported by clinical validation and a strong consumer testimonial base.
Technology Platform
Non-invasive, wearable neuromodulation device that delivers electrical pulses to the median nerve on the wrist to modulate signals to the brain's nausea control centers.
Opportunities
Risk Factors
Competitive Landscape
Competitors include traditional OTC antiemetic drugs (e.g., dimenhydrinate, meclizine), prescription antiemetics, acupressure bands (e.g., Sea-Band), and emerging bioelectronic medicine companies. Reliefband's key differentiators are its FDA clearance for multiple medical indications, clinical validation, and positioning as a durable, reusable electronic device versus passive or pharmaceutical options.